| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 74 | 23.9x | 18.2x | Top tier | |
Growth | 24 | 10.9% | 7.1% | Bottom tier | |
Quality | 43 | 5.5% | 4.5% | Around median | |
Safety | 57 | 2.1x | 2.6x | Around median | |
Capital Return | 35 | 3.80% | 2.10% | Bottom tier | |
Momentum | 54 | -17.6% | 2.9% | Around median | |
Sentiment | 49 | 2 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
ICL Group operates through an interconnected portfolio of minerals, fertilizers, and specialty solutions. Its businesses include potash and phosphate fertilizers, bromine products, flame retardants, and clear brine fluids, alongside specialty crop nutrition, food phosphates, and functional ingredients. The company leverages its resources in the Dead Sea, Spain, the Negev, and China, and generates revenue from the agriculture, food, electronics, energy, construction, and oil and gas markets.
In Q2 FY2026, sales rose 17% year over year to $2.1 billion, and adjusted earnings before interest, taxes, depreciation, and amortization increased 28% to $448 million, representing a margin of approximately 21.3%. Adjusted net income rose 35% to $149 million, or $0.12 per share, while operating cash flow reached $290 million and free cash flow reached $94 million, up 8% and 34% year over year, respectively.
All four segments contributed to growth in Q2 FY2026: Industrial Products recorded sales of approximately $414 million and earnings before interest, taxes, depreciation, and amortization of $130 million; Potash recorded approximately $468 million and $154 million; Phosphate Solutions recorded approximately $722 million and $136 million; and Growing Solutions recorded approximately $605 million and $50 million, respectively. The improvement came from higher potash, bromine, and phosphate prices and volumes, but coincided with $100 million in additional raw material costs and more than $40 million in foreign exchange impact.
The analyst consensus on ICL is Neutral, with an average price target of $6.08 and a range of $5.75 to $6.50; the average target falls within the 52-week range of $4.76 to $6.97 and is approximately 13% below its peak. No price-to-earnings multiple is available in the provided data, while the valuation balances the improvement in Q2 FY2026 against the decline in net income from $2.2 billion in FY2022 to $280 million in FY2025 and the risks of margin pressure during the second half of FY2026.
Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.
Sales rose 17% to $2.1 billion, with improved pricing alone adding $206 million to revenue and volumes making a positive contribution. Adjusted earnings before interest, taxes, depreciation, and amortization increased 28% to $448 million, while adjusted net income rose 35% to $149 million. Industrial Products was the most prominent contributor, with sales growing 30% and earnings before interest, taxes, depreciation, and amortization jumping 88% due to bromine prices, volumes, and electronics demand.
ICL launched the Elevate program to reduce its cost base, expand margins, and improve cash generation across more than 40 production sites and an extensive logistics chain. The program targets an annual improvement in earnings before interest, taxes, depreciation, and amortization exceeding $150 million by the end of 2027 and more than $350 million by the end of 2028. The target is for 50% to 60% of the savings to come from productivity and operational efficiency, 30% to 40% from external spending, and the remainder from optimizing selling, general, and administrative expenses.
Sulfur is a key raw material for ICL's phosphate products, and its spot price rose 72% quarter over quarter and more than 210% year over year in Q2 FY2026. Lower-cost sulfur inventory helped mitigate the impact in that quarter, but management expects greater margin pressure when higher-priced inventory is consumed. The company secured its needs for Q3 and the beginning of Q4 FY2026, while pricing and supply availability remain challenging.
Automated analysis for informational purposes only — not investment advice.
ICL identified Specialty Crop Nutrition and Specialty Food Solutions as two key drivers of profitable growth. Specialty Crop Nutrition sales increased from $1 billion in 2020 to $2 billion in 2025, while its earnings before interest, taxes, depreciation, and amortization rose from approximately $60 million to more than $200 million. In Specialty Food Solutions, the company targets sales of $1.5 billion by 2029 and is working on applications including low-sodium products, clean-label products, and a high-protein beverage prototype for the GLP-1 category.
On August 5, 2026, management reaffirmed its expectation for consolidated earnings before interest, taxes, depreciation, and amortization of between $1.5 billion and $1.7 billion in FY2026. It also expects potash sales of between 4.5 million and 4.7 million metric tons and an adjusted tax rate of approximately 30%. Despite the strong first half, management expects the second half to be weaker because of higher sulfur prices, shekel exchange-rate risk, and weakness in Growing Solutions in Brazil.
Beginning in Q1 FY2027, ICL will present its businesses within four segments: Nutrition Solutions, Industrial Products, Growing Solutions, and Essential Minerals. Nutrition Solutions will combine the food, beverage, health, and nutrition businesses, while Essential Minerals will include potash and phosphate fertilizers from the core production sites. The structure aims to increase the visibility of the performance of growth drivers and industrial markets, including advanced electronics, semiconductors, AI infrastructure, and data centers.
